Saturday, November 2, 2024
Canada’s Politics and Government News Source Since 1989
Saturday, November 2, 2024 | Latest Paper

Brett Skinner

Opinion | BY BRETT SKINNER | July 4, 2022
Policymakers tend to see the prices of innovative medicines, but not the value, and this has resulted in a huge bureaucracy built to control the cost of patented drugs, writes Brett Skinner. Photograph courtesy of Pixabay
Opinion | BY BRETT SKINNER | July 4, 2022
Opinion | BY BRETT SKINNER | July 4, 2022
Policymakers tend to see the prices of innovative medicines, but not the value, and this has resulted in a huge bureaucracy built to control the cost of patented drugs, writes Brett Skinner. Photograph courtesy of Pixabay
Opinion | BY BRETT SKINNER | July 4, 2022
Policymakers tend to see the prices of innovative medicines, but not the value, and this has resulted in a huge bureaucracy built to control the cost of patented drugs, writes Brett Skinner. Photograph courtesy of Pixabay
Opinion | BY BRETT SKINNER | July 4, 2022
Opinion | BY BRETT SKINNER | July 4, 2022
Policymakers tend to see the prices of innovative medicines, but not the value, and this has resulted in a huge bureaucracy built to control the cost of patented drugs, writes Brett Skinner. Photograph courtesy of Pixabay